INTI
Inhibitor Therapeutics, Inc.Company with tickers: INTI
CIK
1042418
CUSIP
45720M105
Shares Outstanding
172,573,545
The company's filings as submitted to the SEC's EDGAR system — 10-K, 10-Q, 8-K, proxy statements and more — listed most recent first.
| Type | Filing Date | Period | Open |
|---|---|---|---|
| 10-Q | 2026-05-15 | 2026-03-31 | |
| 8-K | 2026-04-01 | — | |
| 10-K | 2026-03-26 | 2025-12-31 | |
| 8-K | 2026-02-24 | — | |
| 10-Q | 2025-11-13 | 2025-09-30 | |
| 8-K | 2025-10-27 | 2025-10-24 | |
| 10-Q | 2025-08-13 | 2025-06-30 | |
| 10-Q | 2025-05-14 | 2025-03-31 | |
| 10-K | 2025-03-28 | 2024-12-31 | |
| 10-Q | 2024-11-12 | 2024-09-30 | |
| 10-Q | 2024-08-06 | 2024-06-30 | |
| 10-Q | 2024-05-13 | 2024-03-31 | |
| 10-K | 2024-03-29 | 2023-12-31 | |
| 8-K | 2023-12-14 | 2023-12-12 | |
| 10-Q | 2023-11-13 | 2023-09-30 | |
| 8-K | 2023-10-18 | 2023-10-13 | |
| 8-K | 2023-08-29 | 2023-08-23 | |
| 10-Q | 2023-08-11 | 2023-06-30 | |
| 8-K | 2023-05-31 | — | |
| 10-Q | 2023-05-15 | 2023-03-31 | |
| 10-K | 2023-03-31 | 2022-12-31 | |
| 8-K | 2022-12-19 | 2022-12-13 | |
| 10-Q | 2022-11-14 | 2022-09-30 | |
| 8-K | 2022-09-15 | 2022-09-09 | |
| 10-Q | 2022-08-12 | 2022-06-30 | |
| 8-K | 2022-06-03 | 2022-06-01 | |
| 10-Q | 2022-05-13 | 2022-03-31 | |
| 10-K | 2022-03-30 | 2021-12-31 | |
| 8-K | 2022-01-18 | 2022-01-13 | |
| 10-Q | 2021-11-12 | 2021-09-30 | |
| 10-Q | 2021-08-13 | 2021-06-30 | |
| 10-Q | 2021-05-14 | 2021-03-31 | |
| 10-K | 2021-03-26 | 2020-12-31 | |
| 8-K | 2021-01-06 | 2020-12-31 | |
| 8-K | 2020-12-17 | 2020-12-12 | |
| 10-Q | 2020-11-16 | 2020-09-30 | |
| 8-K | 2020-09-23 | 2020-09-17 | |
| 10-Q | 2020-08-12 | 2020-06-30 | |
| 8-K | 2020-06-30 | 2020-06-28 | |
| 8-K | 2020-06-08 | 2020-06-04 | |
| 8-K | 2020-05-06 | 2020-05-03 | |
| 10-Q | 2020-05-01 | 2020-03-31 | |
| 8-K | 2020-04-16 | 2020-04-10 | |
| 10-K | 2020-03-30 | 2019-12-31 | |
| 8-K | 2020-01-03 | 2019-12-31 |
Showing 1–45 of 45 filings